Reactive oxygen species mediate Epstein-Barr virus reactivation by N-methyl-N'-nitro-N-nitrosoguanidine
about
Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesisIdentification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial MalignanciesEffect of mitochondrially targeted carboxy proxyl nitroxide on Akt-mediated survival in Daudi cells: Significance of a dual mode of actionEGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells.Anti-Helicobacter pylori Antibody Profiles in Epstein-Barr virus (EBV)-Positive and EBV-Negative Gastric Cancer.Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS.Roles of reactive oxygen species in cell signaling pathways and immune responses to viral infections.DNA Oncogenic Virus-Induced Oxidative Stress, Genomic Damage, and Aberrant Epigenetic AlterationsEpstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.Rta-IgG as a biomarker for diagnosis and post treatment prognostic of nasopharyngeal carcinoma.Inactivation of HMGCL promotes proliferation and metastasis of nasopharyngeal carcinoma by suppressing oxidative stress.Combination of betulinic acid and chidamide synergistically inhibits Epstein-Barr virus replication through over-generation of reactive oxygen species.Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors.Perspectives of Phage-Eukaryotic Cell Interactions to Control Epstein-Barr Virus Infections.Perspective: Contribution of Epstein-Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells.
P2860
Q28079510-CEF0FCF5-155F-43B8-B66A-39FCB19BFFC4Q28551855-14803166-FEAE-4881-8AE0-68F6F1566EAAQ33584645-50FA0BA0-3EC3-462D-98AC-972710259761Q35138905-A3F43DF1-6F53-4E94-9B52-D71C89324F3FQ37213462-929A37A6-B7AE-45BF-B3E8-5DBFEE24411FQ37392894-60651305-702D-4DB9-A88A-15BC5EBE0C6CQ39009732-2E414C74-7E23-423E-993C-0385EEB1F43BQ39455821-DE647F88-58A5-499E-A22D-27E31043EFE1Q40207035-72D27B72-AC95-4103-A5F2-8BC4C3828E9EQ40808607-C011A667-8D24-4C60-896E-EE4EDE21473EQ41696827-ADDD7E4F-6E13-4881-AB2B-78E168F6FAB4Q41924415-D5C3D2A7-EEA3-41FC-870B-D3DA6DB00504Q45324502-A5B71196-6E01-4F18-9CFF-FE96AE7FFA98Q53694309-10E270C9-37DC-4139-8D3A-0DBCEA2768ACQ54232271-42F049B0-71A7-4FBB-A0DB-1991A49A83A9
P2860
Reactive oxygen species mediate Epstein-Barr virus reactivation by N-methyl-N'-nitro-N-nitrosoguanidine
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Reactive oxygen species mediat ...... yl-N'-nitro-N-nitrosoguanidine
@ast
Reactive oxygen species mediat ...... yl-N'-nitro-N-nitrosoguanidine
@en
Reactive oxygen species mediat ...... yl-N'-nitro-N-nitrosoguanidine
@nl
type
label
Reactive oxygen species mediat ...... yl-N'-nitro-N-nitrosoguanidine
@ast
Reactive oxygen species mediat ...... yl-N'-nitro-N-nitrosoguanidine
@en
Reactive oxygen species mediat ...... yl-N'-nitro-N-nitrosoguanidine
@nl
prefLabel
Reactive oxygen species mediat ...... yl-N'-nitro-N-nitrosoguanidine
@ast
Reactive oxygen species mediat ...... yl-N'-nitro-N-nitrosoguanidine
@en
Reactive oxygen species mediat ...... yl-N'-nitro-N-nitrosoguanidine
@nl
P2093
P2860
P3181
P1433
P1476
Reactive oxygen species mediat ...... yl-N'-nitro-N-nitrosoguanidine
@en
P2093
Chih-Yeu Fang
Ching-Hwa Tsai
Chung-Chun Wu
Jen-Yang Chen
Sheng-Yen Huang
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0084919
P407
P50
P577
2013-12-20T00:00:00Z